metabolism of oxycodone through the Stage I and II pathways. Additionally, it examined the effect of oxycodone within the related CYP and UGT enzymes.This figure reveals schematically the descending inhibitory pathways. Regions shaded gray display a high expression of opioid receptors and their endogenous ligands. MOP agonists deliver analgesia bot